Are you interested in translating laboratory research into a marketable product? The National Cancer Institute’s (NCI) Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) Programs provide funding that supports the development and commercialization of new cancer technologies to prevent, diagnose, and treat cancer.
You are invited to join NCI SBIR Program Directors Dr. Andrew Kurtz and Dr. Greg Evans at a session being held on Monday, April 2, 2012 at the American Association for Cancer Research (AACR) 103rd Annual Meeting to learn more about SBIR & STTR funding opportunities and other NCI initiatives that are helping small businesses and research institutions commercialize new cancer innovations.
American Association for Cancer Research Annual Meeting – NCI SBIR & STTR Session
NCI SBIR & STTR: Advancing the Commercialization of New Cancer Innovations
Date: Monday, April 2, 2012
Time: 12:00pm – 1:30pm (CST)
Location: Room W194, McCormick Place West, Chicago, IL
In this session, Dr. Kurtz and Dr. Evans will discuss:
- SBIR & STTR program details and eligibility requirements
- NCI’s research priorities for small businesses
- Tips on how to submit a successful application
- Special NCI initiatives to foster external partnerships and investments
Additionally during the session, Dr. Jim Olson of the Fred Hutchinson Cancer Research Center will discuss lessons learned from his own experiences in working with the SBIR & STTR Program. Participants will have the opportunity to learn how this team leveraged STTR funding to successfully translate a novel technology from an academic cancer center into a small business and promising commercial opportunity.
Please Note: If you are interested in attending the session above, please send an email with your name, telephone number, and the name of your organization to: firstname.lastname@example.org. Registration is free for this SBIR session only. If you are planning on attending the rest of the AACR meeting, regular conference registration fees apply.
The SBIR & STTR Programs are NCI’s engine of innovation for developing and commercializing novel technologies and products to prevent, diagnose, and treat cancer. The SBIR & STTR Programs are government set-aside programs for domestic small businesses to engage in research and development that has the potential for commercialization and public benefit.
Sign up to receive updates about
SBIR & STTR funding opportunities at